Hiroki Teraoku
- Co-authors
- Mitsuo ShimadaTetsuya IkemotoYuji MorineYu SaitoShinichiro YamadaSatoru ImuraMasato YoshikawaChie Takasu
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (13 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers)Liver Disease Diagnosis and Treatment (6 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hiroki Teraoku
35 papers receiving 349 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 116
- Oncology 107
- Hepatology 97
- Surgery 96
- Cancer Research 73
Countries citing papers authored by Hiroki Teraoku
This map shows the geographic impact of Hiroki Teraoku's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroki Teraoku with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroki Teraoku more than expected).
Fields of papers citing papers by Hiroki Teraoku
This network shows the impact of papers produced by Hiroki Teraoku. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroki Teraoku. The network helps show where Hiroki Teraoku may publish in the future.
Co-authorship network of co-authors of Hiroki Teraoku
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroki Teraoku. A scholar is included among the top collaborators of Hiroki Teraoku based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroki Teraoku. Hiroki Teraoku is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 0 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 27 | |
| 8 | 1 | |
| 9 | 2 | |
| 10 | 1 | |
| 11 | 3 | |
| 12 | 4 | |
| 13 | 3 | |
| 14 | 14 | |
| 15 | 10 | |
| 16 | 15 | |
| 17 | 8 | |
| 18 | Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma. | 18 |
| 19 | 12 | |
| 20 | 18 |
About Hiroki Teraoku
Hiroki Teraoku is a scholar working on Hepatology, Oncology and Cancer Research, having authored 44 papers that have together received 352 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (13 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Liver Disease Diagnosis and Treatment (6 papers). The work is most often cited by research in Hepatology (97 citations), Cancer Research (73 citations) and Oncology (107 citations). Hiroki Teraoku has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Mitsuo Shimada, Tetsuya Ikemoto, Yuji Morine, Yu Saito, Shinichiro Yamada, Satoru Imura, Masato Yoshikawa, Chie Takasu, Daichi Ishikawa and Shuichi Iwahashi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.